Idarubicin doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma.

Background: Liver cancer is the fifth most common cancer and the second cause of cancer-related deaths worldwide. Transarterial chemoembolization (TACE) is the best treatment of intermediate hepatocellular carcinoma (HCC). Doxorubicin is the most commonly used drug despite a low level of evidence.